ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Philadelphia, PA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Non-Small-Cell Lung Carcinoma
Cancer
Neoplasm Metastasis
Ovarian Cancer
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck

Breast Cancer trials near Philadelphia, PA, USA:

Phase 1 Study of CLR 125 in Triple Negative Breast Cancer

dose levels of CLR 125 in patients with advanced triple negative breast cancer. The main questions the study aims to answer are:* W ...

Enrolling
Breast Cancer
Drug: CLR 125
Drug: Iopofosine I 131

Phase 1

Cellectar Biosciences

Princeton, New Jersey, United States and 2 other locations

This research study is for patients with metastatic breast cancer.* Metastatic means that the cancer has spread beyond the ...

Active, not recruiting
Somatic Mutation Breast Cancer (BRCA1)
Somatic Mutation Breast Cancer (BRCA2)
Drug: Olaparib

Phase 2

Beth Israel Lahey Health
Beth Israel Lahey Health

Philadelphia, Pennsylvania, United States and 19 other locations

This study is being done to look at the role of continuing palbociclib treatment in combination with another type of hormonal therapy (fulvestrant) a...

Active, not recruiting
Metastatic Breast Cancer
Drug: Palbociclib
Drug: Fulvestrant

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

West Reading, Pennsylvania, United States and 4 other locations

Status recently updated

The goal of this clinical trial is to study the safety, feasibility, histologic and immunological effects of Mitazalimab, a CD40 agonistic antibody,...

Not yet enrolling
Enrolling
Breast Cancer
Drug: Intratumoral Mitazalimab
Drug: Intratumoral Nivolumab

Early Phase 1

Jennifer Zhang

Philadelphia, Pennsylvania, United States

This clinical trial will assess the safety and early efficacy of Hydroxychloroquine or Avelumab, with or without Palbociclib, in early-stage ER+ breast...

Enrolling
Breast Cancer
Drug: Avelumab
Drug: Palbociclib

Phase 2

Abramson Cancer Center at Penn Medicine
Abramson Cancer Center at Penn Medicine

Philadelphia, Pennsylvania, United States and 6 other locations

The purpose of this study is to find out the possible anti-cancer effect of pelareorep in combination with chemotherapy \[paclitaxel\] and a ...

Active, not recruiting
Breast Cancer Metastatic
Drug: Avelumab
Drug: Paclitaxel

Phase 2

Oncolytics Biotech

Philadelphia, Pennsylvania, United States and 17 other locations

contrast-enhanced spectral mammography (CESM) can detect more cancers with fewer false positives than digital breast tomosynthesis -...

Enrolling
Breast Cancer
Diagnostic Test: Dual-Energy Contrast-Enhanced Spectral Mammography (CESM)
American College of Radiology (ACR)

Philadelphia, Pennsylvania, United States and 10 other locations

A phase 1 study of 68Ga-R11228 and 177Lu-R11228 in breast cancer....

Enrolling
Metastatic Hormone Receptor Positive Breast Cancer
Locoregionally Recurrent Hormone-receptor Positive Breast Cancer
Drug: 68Ga-R11228
Drug: 177Lu-R11228

Phase 1

Radionetics Oncology

Princeton, New Jersey, United States and 6 other locations

Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...

Enrolling
Breast Cancer
Breast Neoplasm
Drug: Cyclophosphamide
Drug: Interferon infiltration of the inoculation site

Phase 3

BriaCell Therapeutics

Flemington, New Jersey, United States and 78 other locations

A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd...

Active, not recruiting
HER2 Positive Metastatic Breast Cancer
Drug: ARX788

Phase 2

Ambrx

Philadelphia, Pennsylvania, United States and 32 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems